BCA-1/BLC (CXCL13), human recombinant

BCA-1/BLC (CXCL13), human recombinant is available at Gentaur for Next week delivery.

A cytokine selectively chemotactic for B cells

Biomolecule/Target: BCA-1/BLC (CXCL13)

Alternates names: B cell Attracting Chemokine-1, CXCL13, BLC (mouse), BLR1 Ligand, Angie, B lymphocyte chemoattractant, CXC chemokine BLC, Small-inducible cytokine B13

Synonyms: B cell Attracting Chemokine-1, CXCL13, BLC (mouse), BLR1 Ligand

Background Information: Human BCA-1 (B Cell-Attracting chemokine 1), also known as BLC or CXCL13, is a recently identified new CXC chemokines. Human BCA-1 is a highly effective attractant for human blood B lymphocytes, but was inactive on freshly isolated or IL-2 stimulated T lymphocytes, monocytes and neutrophils. The human BCA-1 is a 10.1 kDa protein containing 85 amino acid residues.

Reconstitution Instructions: Centrifuge the vial prior to opening. Reconstitute in H₂O to a concentration of 0.1-1 mg/ml. The solution can then be diluted into other aqueous buffers or store at 4°C for 1 week or -20°C for future use.

NCBI Gene Symbol: CXCL13

Gene ID: 10565

NCBI Accession: O43929